• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Allkem and Livent Receive All Required Regulatory Approvals Globally to Close Merger of Equals

    11/14/23 3:24:00 PM ET
    $LTHM
    Major Chemicals
    Industrials
    Get the next $LTHM alert in real time by email

    PHILADELPHIA, Nov. 14, 2023 /PRNewswire/ -- Livent Corporation (NYSE:LTHM) announced that Arcadium Lithium plc ("NewCo"), the new holding company of the combined group that will result from the proposed merger of Allkem and Livent, has now received all required pre-closing regulatory approvals in connection with the proposed merger of equals between Allkem and Livent (the "Transaction"). This includes antitrust approvals in Canada, China, Japan, South Korea and the U.S., as well as completion of investment screenings in Australia, the U.K. and the U.S.

    Livent Corporation (PRNewsfoto/Livent Corporation)

    Allkem and Livent are targeting closing of the Transaction on January 4, 2024. The closing of the Transaction remains subject to approval by both Livent and Allkem shareholders, and Australian Court approval of the Scheme.

    About Livent

    For nearly eight decades, Livent has partnered with its customers to safely and sustainably use lithium to power the world. Livent is one of only a small number of companies with the capability, reputation, and know-how to produce high-quality finished lithium compounds that are helping meet the growing demand for lithium. The Company has one of the broadest product portfolios in the industry, powering demand for green energy, modern mobility, the mobile economy, and specialized innovations, including light alloys and lubricants. Livent has a combined workforce of approximately 1,350 full-time, part-time, temporary, and contract employees and operates manufacturing sites in the United States, England, China and Argentina. For more information, visit Livent.com.

    Important Information and Legal Disclaimer:

    Forward-Looking Statements

    This announcement contains forward-looking statements, including within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can often be identified by terms such as "may," "will," "appears," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern expectations, strategy, plans, or intentions. However, the absence of these words or similar terms does not mean that a statement is not forward-looking. All forward-looking statements are based on information and estimates available to Allkem or Livent at the time of this announcement and are not guarantees of future performance.

    Examples of forward-looking statements in this announcement (made at the date of this announcement unless otherwise indicated) include, among others, statements regarding the future performance of the combined company, the perceived and potential synergies and other benefits of the Transaction, and expectations around the financial impact of the Transaction on the combined company's financials. In addition, this announcement contains statements concerning the intentions, beliefs and expectations, plans, strategies and objectives of the directors and management of Allkem and Livent for Allkem, Livent and the combined company, the anticipated timing for and outcome and effects of the Transaction (including expected benefits to shareholders of Allkem and Livent), anticipated production, production capacity or construction or development commencement dates, costs or production outputs, capital expenditure and future demand for lithium, expectations for the ongoing development and growth potential of the combined company and the future operation of Allkem, Livent and the combined company.

    Forward-looking statements are not statements of historical fact and actual events and results may differ materially from those contemplated by the forward-looking statements as a result of a variety of known and unknown risks, uncertainties, and other factors (many of which are outside the control of Allkem, Livent and the combined company), some of which are described from time to time in Livent's filings with the Securities and Exchange Commission ("SEC") and Allkem's filings with the ASX, including Livent's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and any subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and Allkem's Annual Report for the financial year ended 30 June 2023, and future filings and reports by either Allkem or Livent.

    These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement and may include statements regarding the expected timing and structure of the Transaction; the ability of the parties to complete the Transaction considering the various closing conditions; the expected benefits of the Transaction, such as improved operations, enhanced revenues and cash flow, synergies, growth potential, market profile, business plans, expanded portfolio and financial strength; the competitive ability and position of NewCo following completion of the Transaction; and anticipated growth strategies and anticipated trends in Livent's, Allkem's and, following the completion of the Transaction, NewCo's business.

    In addition, other factors related to the Transaction between Allkem and Livent that contribute to the uncertain nature of the forward-looking statements and that could cause actual results and financial condition to differ materially from those expressed or implied include, but are not limited to: the satisfaction of the conditions precedent to the consummation of the Transaction, including, without limitation, the receipt of shareholder and regulatory approvals on the terms desired or anticipated; unanticipated difficulties or expenditures relating to the Transaction, including, without limitation, difficulties that result in the failure to realize expected synergies, efficiencies and cost savings from the Transaction within the expected time period (if at all); potential difficulties in Allkem's and Livent's ability to retain employees as a result of the announcement and pendency of the Transaction; risks relating to the value of NewCo's shares to be issued in the Transaction; disruptions of Allkem's and Livent's current plans, operations and relationships with customers caused by the announcement and pendency of the Transaction; legal proceedings that may be instituted against Allkem and Livent following announcement of the Transaction; funding requirements; lithium and other commodity prices; exploration, development and operating risks (including unexpected capital or operating costs); production risks; regulatory restrictions (including environmental regulations and associated liability, changes in regulatory restrictions or regulatory policy and potential title disputes) and risks associated with general economic conditions.

    Additional factors that could cause actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements are detailed in the filings with the SEC, including Livent's annual report on Form 10-K, periodic quarterly reports on Form 10-Q, periodic Current Reports on Form 8-K and other documents filed with the SEC.

    There can be no assurance that the Transaction will be implemented or that plans of the directors and management of Allkem and Livent for the combined company will proceed as currently expected or will ultimately be successful. Investors are strongly cautioned not to place undue reliance on forward-looking statements, including in respect of the financial or operating outlook for Allkem, Livent or the combined company (including the realization of any expected synergies).

    Except as required by applicable law or the ASX Listing Rules, Allkem and Livent assume no obligation to, and expressly disclaim any duty to, provide any additional or updated information or to update any forward-looking statements, whether as a result of new information, future events or results, or otherwise. Nothing in this announcement will, under any circumstances (including by reason of this announcement remaining available and not being superseded or replaced by any other presentation or publication with respect to Allkem, Livent or the combined company, or the subject matter of this announcement), create an implication that there has been no change in the affairs of Allkem or Livent since the date of this announcement. The distribution of this announcement may be subject to legal or regulatory restrictions in certain jurisdictions. Any person who comes into possession of this announcement must inform himself or herself of and comply with any such restrictions.

    No Offer or Solicitation

    This communication is for informational purposes only and is not intended to be and shall not constitute a solicitation of any vote or approval, or an offer to buy or sell, or the solicitation of an offer to buy or sell, any securities, or an invitation or recommendation to subscribe for, acquire or buy securities of Allkem, Livent or NewCo, or any other financial products or securities, in any place or jurisdiction, nor shall there be any offer, solicitation or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made in the United States absent registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from, or in a transaction not subject to, such registration requirements.

    Additional Information and Where to Find it

    On July 20, 2023, NewCo filed with the SEC a registration statement on Form S-4, as amended by Amendment No. 1 filed on September 26, 2023, Amendment No. 2 filed on September 27, 2023, Amendment No. 3 filed on October 30, 2023 and Amendment No. 4 filed on October 30, 2023 that contains a proxy statement/prospectus and other documents (the "Form S-4"). The Form S-4 has not yet been declared effective by the SEC. Although the Form S-4 has not yet become effective and the information contained therein is subject to change, it provides important information about the Transaction. Livent will mail the proxy statement/prospectus contained in the Form S-4 to its stockholders. This communication is not a substitution for any registration statement, proxy statement/prospectus or other documents that may be filed with the SEC in connection with the Transaction.

    INVESTORS SHOULD READ THE PROXY STATEMENT/PROSPECTUS AND SUCH OTHER DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THE PROXY STATEMENT/PROSPECTUS AND SUCH DOCUMENTS, BEFORE THEY MAKE ANY DECISION WITH RESPECT TO THE TRANSACTION BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NEWCO, LIVENT, ALLKEM, THE TRANSACTION AND RELATED MATTERS. The Form S-4, the proxy statement/prospectus, any amendments or supplements thereto and all other documents filed with the SEC in connection with the Transaction is or will be available when filed free of charge on the SEC's web site at www.sec.gov. Copies of documents filed with the SEC by Livent will be made available free of charge on Livent's investor relations website (at https://ir.livent.com/overview/default.aspx).

    Participants in the Solicitation

    Livent, Allkem, NewCo and certain of their respective directors and executive officers and other members of their respective management and employees may be deemed to be participants in the solicitation of proxies in connection with the Transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the Transaction, including a description of their direct or indirect interests in the Transaction, by security holdings or otherwise, will be set forth in the proxy statement/prospectus and other relevant materials when it is filed with the SEC. Information regarding the directors and executive officers of Livent is contained in Livent's proxy statement for its 2023 annual meeting of stockholders, filed with the SEC on March 16, 2023, its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on February 24, 2023, subsequent statements of beneficial ownership on file with the SEC and other filings made from time to time with the SEC. Information about Allkem's directors and executive officers is set forth in Allkem's latest annual report dated 22 August 2023, as updated from time to time via announcements made by Allkem on the Australian Securities Exchange. These documents can be obtained free of charge from the sources indicated above.

    Media contact: Juan Carlos Cruz +1.215.299.6725

    [email protected]

    Investor contact: Daniel Rosen +1.215.299.6208

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allkem-and-livent-receive-all-required-regulatory-approvals-globally-to-close-merger-of-equals-301988146.html

    SOURCE Livent Corporation

    Get the next $LTHM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LTHM

    DatePrice TargetRatingAnalyst
    12/5/2023$18.00 → $15.00Neutral → Underweight
    Piper Sandler
    10/25/2023$33.00 → $19.00Overweight → Neutral
    Piper Sandler
    10/25/2023$27.00 → $21.00Hold → Buy
    Deutsche Bank
    5/11/2023$32.00Neutral → Buy
    B. Riley Securities
    5/11/2023$30.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/5/2023$29.00 → $27.00Neutral → Buy
    BofA Securities
    2/16/2023$26.00 → $29.00Buy → Neutral
    BofA Securities
    1/11/2023$26.00Underperform → Buy
    BofA Securities
    More analyst ratings

    $LTHM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Metals Acquisition Limited Announces Appointment of Leanne Heywood to the Board of Directors

      Metals Acquisition Limited (NYSE:MTAL, ASX:MAC))) Metals Acquisition Limited ARBN 671 963 198 (NYSE:MTAL, ASX: MAC))), a private limited company incorporated under the laws of Jersey, Channel Islands ("MAC" or the "Company") is pleased to announce the appointment of Ms. Leanne Heywood as a Non-Executive Director to the Company's Board of Directors, effective 1 May 2024. Ms. Heywood is an experienced non-executive director with broad general management experience gained through an international career in the mining sector, including 10 years with the Rio Tinto Copper Group. Ms. Heywood currently serves as a non-executive director, and is responsible for a diverse range of committee cha

      5/1/24 6:30:00 AM ET
      $LTHM
      $MTAL
      Major Chemicals
      Industrials
      Metal Mining
      Basic Materials
    • Arcadium Lithium Announces Date for Fourth Quarter 2023 Earnings Release and Webcast Conference Call

      PHILADELPHIA and PERTH, Australia, Jan. 23, 2024 /PRNewswire/ -- Arcadium Lithium plc (NYSE:ALTM, ASX: LTM, ", Arcadium Lithium", ))) today announced it will release fourth quarter 2023 earnings results on Thursday, February 22, 2024, after stock market close via PR Newswire and the company's investor relations website at: https://ir.arcadiumlithium.com.  The company will subsequently host a webcast conference call on Thursday, February 22, 2024 at 5:00 p.m. ET (6:00 a.m. AWST, 9:00 a.m. AEDT on Friday, February 23, 2024) that is open to the public via Internet broadcast. Inte

      1/23/24 5:00:00 PM ET
      $ALTM
      $LTHM
      Major Chemicals
      Industrials
    • Livent Set to Join S&P MidCap 400; NCR Voyix and Rush Enterprises to Join S&P SmallCap 600

      NEW YORK, Dec. 19, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Tuesday, January 2: S&P SmallCap 600 constituent Livent Corp. (NYSE:LTHM) will replace NCR Voyix (NYSE:VYX) in the S&P MidCap 400, and NCR Voyix will replace Livent in the S&P SmallCap 600. Allkem Limited (ASX: AKE) is merging with Livent in a transaction expected to be completed on or about Thursday, January 4 pending final conditions. The combined company will be considered US domiciled for index purposes, and Livent will be treated as the surviving entity. Post merger, the company will be named Arcadium Lithium

      12/19/23 5:49:00 PM ET
      $KIM
      $LTHM
      $RPT
      $RUSHA
      Real Estate Investment Trusts
      Real Estate
      Major Chemicals
      Industrials

    $LTHM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Livent downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Livent from Neutral to Underweight and set a new price target of $15.00 from $18.00 previously

      12/5/23 7:31:29 AM ET
      $LTHM
      Major Chemicals
      Industrials
    • Livent downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded Livent from Overweight to Neutral and set a new price target of $19.00 from $33.00 previously

      10/25/23 6:20:45 AM ET
      $LTHM
      Major Chemicals
      Industrials
    • Livent upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Livent from Hold to Buy and set a new price target of $21.00 from $27.00 previously

      10/25/23 6:20:14 AM ET
      $LTHM
      Major Chemicals
      Industrials

    $LTHM
    Financials

    Live finance-specific insights

    See more
    • Arcadium Lithium Announces Date for Fourth Quarter 2023 Earnings Release and Webcast Conference Call

      PHILADELPHIA and PERTH, Australia, Jan. 23, 2024 /PRNewswire/ -- Arcadium Lithium plc (NYSE:ALTM, ASX: LTM, ", Arcadium Lithium", ))) today announced it will release fourth quarter 2023 earnings results on Thursday, February 22, 2024, after stock market close via PR Newswire and the company's investor relations website at: https://ir.arcadiumlithium.com.  The company will subsequently host a webcast conference call on Thursday, February 22, 2024 at 5:00 p.m. ET (6:00 a.m. AWST, 9:00 a.m. AEDT on Friday, February 23, 2024) that is open to the public via Internet broadcast. Inte

      1/23/24 5:00:00 PM ET
      $ALTM
      $LTHM
      Major Chemicals
      Industrials
    • Livent Announces Date for Third Quarter 2023 Earnings Release and Webcast Conference Call

      PHILADELPHIA, Oct. 9, 2023 /PRNewswire/ -- Livent Corporation (NYSE:LTHM) today announced it will release its third quarter 2023 earnings on Tuesday, October 31, 2023, after stock market close via PR Newswire and the company's website at: http://www.livent.com.  The company will subsequently host a webcast conference call on Tuesday, October 31, 2023, at 4:30 p.m. ET that is open to the public via Internet broadcast and conference call. Internet broadcast: http://www.livent.com. Dial-in telephone numbers:U.S. / Canada: (888) 330-2454International: (240) 789-2714Conference ID #

      10/9/23 4:05:00 PM ET
      $LTHM
      Major Chemicals
      Industrials
    • Livent Announces Date for Second Quarter 2023 Earnings Release and Webcast Conference Call

      PHILADELPHIA, July 10, 2023 /PRNewswire/ -- Livent Corporation (NYSE:LTHM) today announced it will release its second quarter 2023 earnings on Thursday, August 3, 2023, after stock market close via PR Newswire and the company's website at: http://www.livent.com.  The company will subsequently host a webcast conference call on Thursday, August 3, 2023, at 4:30 p.m. ET that is open to the public via Internet broadcast and conference call. Internet broadcast: http://www.livent.com. Dial-in telephone numbers:U.S. / Canada: (888) 330-2454International: (240) 789-2714Conference ID #

      7/10/23 4:05:00 PM ET
      $LTHM
      Major Chemicals
      Industrials

    $LTHM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Livent Corporation

      SC 13G - Livent Corp. (0001742924) (Subject)

      2/8/24 10:14:32 AM ET
      $LTHM
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Livent Corporation (Amendment)

      SC 13G/A - Livent Corp. (0001742924) (Subject)

      1/23/24 11:52:30 AM ET
      $LTHM
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by Livent Corporation

      SC 13G - Livent Corp. (0001742924) (Subject)

      1/8/24 4:27:32 PM ET
      $LTHM
      Major Chemicals
      Industrials

    $LTHM
    Leadership Updates

    Live Leadership Updates

    See more
    • Metals Acquisition Limited Announces Appointment of Leanne Heywood to the Board of Directors

      Metals Acquisition Limited (NYSE:MTAL, ASX:MAC))) Metals Acquisition Limited ARBN 671 963 198 (NYSE:MTAL, ASX: MAC))), a private limited company incorporated under the laws of Jersey, Channel Islands ("MAC" or the "Company") is pleased to announce the appointment of Ms. Leanne Heywood as a Non-Executive Director to the Company's Board of Directors, effective 1 May 2024. Ms. Heywood is an experienced non-executive director with broad general management experience gained through an international career in the mining sector, including 10 years with the Rio Tinto Copper Group. Ms. Heywood currently serves as a non-executive director, and is responsible for a diverse range of committee cha

      5/1/24 6:30:00 AM ET
      $LTHM
      $MTAL
      Major Chemicals
      Industrials
      Metal Mining
      Basic Materials
    • Livent Set to Join S&P MidCap 400; NCR Voyix and Rush Enterprises to Join S&P SmallCap 600

      NEW YORK, Dec. 19, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Tuesday, January 2: S&P SmallCap 600 constituent Livent Corp. (NYSE:LTHM) will replace NCR Voyix (NYSE:VYX) in the S&P MidCap 400, and NCR Voyix will replace Livent in the S&P SmallCap 600. Allkem Limited (ASX: AKE) is merging with Livent in a transaction expected to be completed on or about Thursday, January 4 pending final conditions. The combined company will be considered US domiciled for index purposes, and Livent will be treated as the surviving entity. Post merger, the company will be named Arcadium Lithium

      12/19/23 5:49:00 PM ET
      $KIM
      $LTHM
      $RPT
      $RUSHA
      Real Estate Investment Trusts
      Real Estate
      Major Chemicals
      Industrials

    $LTHM
    SEC Filings

    See more
    • SEC Form 15-12G filed by Livent Corporation

      15-12G - Livent Corp. (0001742924) (Filer)

      1/22/24 7:20:50 AM ET
      $LTHM
      Major Chemicals
      Industrials
    • SEC Form 25-NSE filed by Livent Corporation

      25-NSE - Livent Corp. (0001742924) (Subject)

      1/10/24 8:57:38 AM ET
      $LTHM
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Livent Corporation

      S-8 POS - Livent Corp. (0001742924) (Filer)

      1/4/24 4:11:03 PM ET
      $LTHM
      Major Chemicals
      Industrials

    $LTHM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Daloia G Peter returned 207,180 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Livent Corp. (0001742924) (Issuer)

      1/8/24 4:18:29 PM ET
      $LTHM
      Major Chemicals
      Industrials
    • Brondeau Pierre R returned 405,421 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Livent Corp. (0001742924) (Issuer)

      1/8/24 4:16:54 PM ET
      $LTHM
      Major Chemicals
      Industrials
    • Pallash Robert C returned 79,977 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Livent Corp. (0001742924) (Issuer)

      1/8/24 4:14:24 PM ET
      $LTHM
      Major Chemicals
      Industrials